Stockreport

Cardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]

Cardiff Oncology, Inc.  (CRDF) 
PDF This compares to loss of $0.20 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 19.23 [Read more]